| Postpartum screening following GDM: how well are we doing? | |
| | |
MedLine Citation:
|
PMID: 20425588 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Once diagnosed with gestational diabetes mellitus (GDM), a woman has a sevenfold increased risk of developing type 2 diabetes relative to women who do not have diabetes during pregnancy. In addition, up to one third of women with GDM have overt diabetes, impaired fasting glucose, or impaired glucose tolerance identified during postpartum glucose screening completed within 6 to 12 weeks. Therefore, the American Diabetes Association, the World Health Organization, and the American College of Obstetricians and Gynecologists currently recommend postpartum glucose screening following GDM. However, despite this recommendation, in many settings the majority of women with GDM fail to return for postpartum glucose testing. Studies conducted to date have not comprehensively examined the health care system, the physician, or the patient determinants of successful screening. These studies are required to help develop standard clinical procedures that enable and encourage all women to return for postpartum glucose screening following GDM. |
| | |
Authors:
|
Kelly J Hunt; Sarah L Logan; Deborah L Conway; Jeffrey E Korte |
Related Documents
:
|
20144328 - Noninvasive optical screening for diabetes. 14693958 - Opportunistic screening for diabetes in routine clinical practice. 1838748 - Phonatory function of neurologically impaired patients. 9560498 - Screening for diabetes on a vascular ward: lessons from an audit. 6357908 - Involvement of ca2+ in the impaired glucose-induced insulin release from islets culture... 2222488 - Relative contribution of glycogenolysis and gluconeogenesis to basal, glucagon- and ner... |
Publication Detail:
|
Type: Journal Article; Research Support, N.I.H., Extramural; Review |
Journal Detail:
|
Title: Current diabetes reports Volume: 10 ISSN: 1539-0829 ISO Abbreviation: Curr. Diab. Rep. Publication Date: 2010 Jun |
Date Detail:
|
Created Date: 2010-04-28 Completed Date: 2010-09-14 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101093791 Medline TA: Curr Diab Rep Country: United States |
Other Details:
|
Languages: eng Pagination: 235-41 Citation Subset: IM |
Affiliation:
|
Division of Biostatistics & Epidemiology/Department of Medicine, Medical University of South Carolina, Suite 303, Charleston, SC 29425, USA. huntke@musc.edu |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Blood Glucose
/
analysis Diabetes, Gestational / blood, diagnosis* Female Health Planning Guidelines Humans Mass Screening* Postpartum Period / blood* Pregnancy |
| Grant Support | |
ID/Acronym/Agency:
|
R01MD004251-02/MD/NCMHD NIH HHS |
| Chemical | |
Reg. No./Substance:
|
0/Blood Glucose |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Glucose monitoring during pregnancy.
Next Document: New insights on glucose pathophysiology in gestational diabetes and insulin resistance.